|
Bioponic supplies ingredients for Hawaiian skin care line
By Simon Pitman
1/29/2007 - Bioponic Phytoceuticals has reached an agreement with Hawaiin skin care specialist Malie to supply ingredients and formulations for a new line of facial tonics.
Bioponics has developed its name in the alternative health and neutraceutical markets with a line of natural-based medicines and tonics that rely on the company's bioresonance formulations...
Bioponic says turmeric product may treat Alzheimer's
By Victoria Harrison
Bioponic Phytoceuticals has reported research suggesting its Curecumin
product may be an important treatment for Alzheimer's disease.
Curecumin is a bioresonant phytotherapeutic form of turmeric. UCLA/VA
researchers found that curcumin, an active compound found in turmeric, may
help the immune system clear the brain of the amyloid beta plaques found in
Alzheimer's disease patients...
Press Release- Source: Bioponic Phytoceuticals, Inc.
Bioponic Phytoceuticals Announces $500,000 Exclusive Production and Sales Agreement with Malie, Inc.
Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that an agreement has been signed with Malie, Inc. of Kauai, Hawaii for the exclusive production of Malie’s new Facial Tonic product line using Bioponic’s proprietary ingredients and formulations. The Company anticipates that the contract will develop into a long-term, multi-million dollar opportunity for its specialized distillation/extraction production capabilities.
The line, currently in production, includes four facial tonics: Rescue (formulated with extractions of Hawaiian grown herbs including -Lilikoi and Lemon Grass); Renew (Ginger and Lime); Purify (Guava and Pineapple); and Beautify (Jasmine and Rose). These products, now being introduced to the Health and Beauty Aid, and spa markets have been featured at the International SPA Association show at Las Vegas, Nevada.
"This is a solid production contract that, over time, will add substantial revenue and profit to our bottom line. We anticipate the contract is worth $500,000 in the next 12 to 18 months. The Malie contract plays to the strengths of both companies, our proprietary technology and formulation expertise and their packaging and marketing savvy," said Steven M. Schorr, Chairman & CEO -Bioponic Phytoceuticals, Inc.
Malie, Inc. is a Kauai, Hawaii company focused in the development and distribution of natural fragrance and personal care products sold into the retail perfume, spa and boutique bodycare markets, including distribution at notable stores such as Nordstrom’s and throughout Europe. http://www.maliekauai.com
Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic™ products (a new healing modality) for sale in the Complementary Alternative Medicine (“CAM”) and natural products markets. Additionally, the Company produces nutraceutical products for the flavor and fragrance industries. The Company has developed several branded product lines in distribution (including the nationally recognized natural nasal spray: Flight Spray). Bioponic is focused on the production of natural products that are used to promote health and well-being. http://www.bioponic.com Contact: Steven M. Schorr/ CEO, Bioponic Phytoceuticals, info@bioponic.com, ph: 808-876-1711
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company’s control that could cause actual results or events to differ materially from current expectations.
Press Release- Source: Bioponic Phytoceuticals, Inc.
Bioponic Phytoceuticals Announces that its Curecumin™ Product May Be An Effective Treatment For Alzheimer’s Disease
Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that its Curecumin™ product (a Bioresonant Phytotherapeutic™ form of Turmeric) may be an important treatment and/or preventative for Alzheimer’s Disease.
UCLA/VA researchers found that curcumin (an active compound found in Turmeric) may help the immune system clear the brain of the amyloid beta plaques found in Alzheimer's disease patients. Recently published in the Journal of Alzheimer's Disease the findings may lead to a new approach in treating Alzheimer's disease by enhancing the natural function of the immune system using curcumin, known for its anti-inflammatory and anti-oxidant properties. According to a research study conducted at UCLA Alzheimer’s Disease Research Center, ”There is substantial in-vitro data indicating that curcumin is a promising agent in the treatment and/or prevention of AD.”
It is estimated by the Alzheimer’s Foundation of America that “Alzheimer's disease currently strikes an estimated 5.8 million Americans. It is projected that the number could more than triple to 16 million by mid-century.”
“We are particularly interested in the potential of our Curecumin™ nasal spray to deliver its benefits directly to the brain through the nasal cavity. If proven effective, we may have an efficacious, cost effective, natural treatment for the millions of Alzheimer’s sufferers, and for those who seek to prevent the disease. With 75 million aging baby boomers the potential for this product is significant." said Steven M. Schorr, Chairman & CEO -Bioponic Phytoceuticals, Inc.
Bioponic Phytoceuticals is engaged in the development, production and distribution of Bioresonant Phytotherapeutic™ products (a new healing modality) for sale in the Complementary Alternative Medicine (“CAM”) and natural products markets. The Company has developed several branded product lines in distribution (including the nationally recognized natural nasal spray: Flight Spray). Bioponic is focused on the production of natural products that are used to promote health and well-being. www.bioponic.com Contact: Steven M. Schorr/ CEO, Bioponic Phytoceuticals, info@bioponic.com, ph: 808-876-1711
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company’s control that could cause actual results or events to differ materially from current expectations.
Press Release- Source: Bioponic Phytoceuticals, Inc.
Special Status Granted
to Bioponic Phytoceuticals Patent Application
Bioponic Phytoceuticals, Inc.. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that its utility patent application “Method of Making Phytotherapeutic Hydrosols” has been granted a “Petition To Make Special” by the United States Patent And Trademark Office. “The petition requests that the application be made special under the accelerated examination procedure set forth in M.P.E.P. 708.02 Section XII: Special status for Applications relating to BIOTECHNOLOGY FIELD.”
The Company’s patent application underlies its Bioresonant Phytotherapeutic product offerings which are currently available, world-wide, through distribution and through the internet at its www.bioponic.com web site and other internet distributors such as Amazon.com and Vocal-care.com.
The patent elucidates a new natural healing modality called Bioresonant Phytotherapeutics, which utilizes the process of tuned sympathetic bioresonance produced in the molecular memory of water molecules, entrained with the phytochemical signature of distilled herbal plants. This process establishes a bioresonant harmonic matrix, which in turn provides healing through optimum bioavailability.
"This is an exciting development for the Company," said Steven M. Schorr, Chairman & CEO -Bioponic Phytoceuticals, Inc. “The opportunity for expedited prosecution of our patent application shortens that wait of patenting and brings the focus of an important intellectual property forward. We believe that this patent, once granted, will provide the Company with a strong ownership position for our Bioresonant Phytotherapeutic products, and will allow us to capture and hold the vast market potential that it addresses.”
Bioponic Phytoceuticals is engaged in the development, formulation, production and distribution of Bioresonant Phytotherapeutic and nutraceutical products for sale in the Complementary Alternative Medicine (“CAM”) and natural products markets. The Company has developed a new healing modality and several branded product lines currently in distribution (including the nationally recognized natural nasal spray: Flight Spray). Bioponic is presently focused on the production of natural products that are used by consumers to promote health and well-being, and to help prevent disease. www.bioponic.com
All statements other than statements of historical fact included in this press release are "forward-looking statements" within the meaning of federal securities laws. Such forward-looking statements are subject to a number of risks and uncertainties, some of which are beyond the Company’s control that could cause actual results or events to differ materially from current expectations.
All-Natural Nasal Spray One of Few Carry-On Liquids Allowed on Planes
Posted on Monday, September 18 @ 15:00:00 CDT
 MN1 Staff Report
MAUI, Hawaii (Sept. 18, 2006) — A nasal spray is the latest line of products developed by a Phytoceuticals company to alleviate nasal dryness specifically related to airline travel.
Bioponic Phytoceuticals, Inc. (PINKSHEETS: BPYT) creates “all natural” products for alternative medicine to cut out the side effects of traditional medicines. In addition, the company provides products which promote herbal healing, skincare, tonics, and herbal remedies. Through an online ordering process, customers can quickly get the products they need, in an all natural form.
The TSA has recently agreed to allow customers admission of up to 4 oz. of non-prescription medicine, which will allow passengers to carry on Flight Spray, despite the ban on carry-on liquids. The spray comes in a 1 oz spray bottle, and is an important health-promoting product for airline passengers.
Flight spray is the first all natural nasal hydration spray formulated especially for airline travelers, and the only liquid product allowed on airlines. The spray can help prevent colds, flu and sore throats due to recycled airplane air and close proximity to those with transmittable symptoms.
Flight spray is just one product of a long line developed by Bioponic Phytoceuticals. BPYT uses its expertise in branding over 12 different product lines by utilizing its proprietary technology.
With so many customers seeking natural remedies, company CEO Steven Schorr, believes there is a substantial marketplace for his companies products.
“The marketplace is actually quite outstanding, and includes the complimentary and alternative medicine markets, which is now $60 billion industry worldwide,” Schorr said in a recent interview with WallstreetReporter.com.
Bioponic’s products, which are formulated for optimum effectiveness, are made from natural and wild-crafted herbs, fruits and spices grown and distilled in Maui, Hawaii.
Press Release Source: Bioponic Phytoceuticals, Inc.
Flight Spray® can fly! Bioponic Phytoceuticals announces its Flight Spray nasal hydration product qualifies under new rules for an exemption from the TSA terrorist plot ban.
MAUI, HAWAII, Date: August 14, 2006 /PRNewswire- / Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that new rules established by the Transportation Safety Administration (“TSA”) on Sunday August 13, 2006 allows for the exemption of Flight Spray from the recently established ban on passengers carrying liquids onto flights. Flight Spray can be used on airplane flights throughout the United States.
The TSA established a ban on liquids being carried onto flights in response to a thwarted terrorist plot revealed on flights originating from Britain. According to the TSA web site exempted products may include “the admission of up to 4 oz. of non-prescription medicine.” These new rules allow Flight Spray, an important health-promoting product for airline passengers, to be carried onto airplanes. Flight Spray comes in a 1 oz. pump spray bottle.
Flight Spray is the first natural nasal hydration spray formulated especially for airline travelers and is the only liquid product used exclusively on airplanes. Used to moisten the nasal passages and alleviate nasal dryness, Flight Spray helps prevent colds, flu and sore throats due to recycled airplane air and close proximity to those with transmittable symptoms. Flight clears the sinuses during long flights. Formulated by combining two of the most effective herbal ingredients (Turmeric root and Spearmint) it provides an unsuitable environment for germs and viruses to reproduce.
"Flight Spray is an beneficial non-prescription remedy for millions of prospective of airline travelers. Our customers rely on Flight Spray to keep them hydrated and healthy during long flights and we are pleased that airline passengers can continue to use our product” said Steven M. Schorr, Chairman & CEO -Bioponic Phytoceuticals, Inc.
Bioponic Phytoceuticalsis engaged in the formulation, production and distribution of natural products for sale in the Complementary Alternative Medicine markets. The Company has developed a new patent pending healing modality “Bioresonant Phytotherapeutics™” and has several branded product lines currently in national distribution. For further information please see www.bioponic.com, and www.flightspray.com
Contact: Steven M. Schorr, CEO
Bioponic Phytoceuticals
info@bioponic.com
phone: 808-876-1711
NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS RELEASE. THE PINK SHEETS LLC DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Press Release Source: Bioponic Phytoceuticals, Inc.
Bioponic Phytoceuticals™ Chairman & CEO Steven M. Schorr discusses corporate plans and strategies in interviews on CEOCast.com and WallstreetReporter.com.
MAUI, HAWAII, Date: August 1, 2006 /PRNewswire- / Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that its Chairman and CEO Steven M. Schorr is featured on both the CEOCast.com and WallstreetReporter.com investor relations web sites.
In two taped interviews aired beginning July 31, 2006, Mr. Schorr details the Company's innovative technology and discusses its successful branded product introductions into the $60 billion Complementary and Alternative Medicinal markets. He also discusses the Companyís entry into the biomedical research arena with its Curecumin™! product's use in research for a treatment for Childhood Hydrocephalus. Mr.Schorr then discusses the Company's strategy to bring its products into the marketplace and its value proposition for shareholder growth and returns.
CEOcast is an online investor relations web site dedicated to featuring interviews of CEOs at public companies. CEOcast's programming is distributed to millions of on-line investors at over 700 financial web sites, 20,000 portfolio managers at more than 3,300 North American institutions, and 7,000 investment research professionals representing over 425 institutions.
The WallStreet Reporter is a premier information source for professionals and features interviews with public company CEOs to more than 80,000 portfolio managers, analysts, venture capitalists, and 3,500 financial editors, reporters, and TV producers. Their website receives 4.5 million hits per month. "The opportunity to deliver our message to millions of potential investors about the Companyís innovative products, vast markets and our entry into the medical biotech arena is an important step in our investor relations program," said Steven M. Schorr, Chairman & CEO -Bioponic Phytoceuticals, Inc.
Bioponic Phytoceuticals™ is engaged in the formulation, production and distribution of Bioresonant Phytotherapeutic™ products for sale in the Complementary Alternative Medicine and natural products markets. The Company has developed a new patent pending healing modality "Bioresonant Phytotherapeutics™" and has several branded product lines currently in national distribution (including the noted natural nasal spray: Flight Spray®). www.bioponic.com, and www.flightspray.com
Contact: Steven M. Schorr, CEO
Bioponic Phytoceuticals
info@bioponic.com
phone: 808-876-1711
Certain statements contained in this press release are forward-looking statements within the meaning of federal securities laws.
NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS RELEASE. THE PINK SHEETS LLC DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Press Release Source: Bioponic Phytoceuticals, Inc.
Bioponic Phytoceuticals Announces Research Agreement With Pediatric Neurosurgery and Childhood Hydrocephalus Center's Dr. J. Pattisapu.
MAUI, Hawaii, July 27 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT - News) today announced that it has signed an agreement with Pediatric Neurosurgery and Childhood Hydrocephalus Center's principal Dr. Jogi Pattisapu to research a treatment for Childhood Hydrocephalus using the Company's Curecumin(TM) product.
Bioponic Phytoceuticals' Curecumin product is the first Bioresonant Phytotherapeutic(TM) formula of curcumin, the active ingredient found in Turmeric root. Curcumin has been found an effective treatment for Cisttic Fibrosis, "It can almost completely correct the measurable defects of the disease," says Michael Caplan at Yale University in New Haven, Connecticut, (Science, vol 304, p 600), and various cancers, "we conclude curcumin is a potent suppressor of cell viability and inducer of apoptosis in melanoma cell lines," says B. Aggarwal of University of Texas M.D. Anderson Cancer Center in Houston. "Curcumin is considered to be a potent cancer chemopreventive agent," (Baum and Ng, 2004; Eybl et al., 2006)," and is recognized by Dr. Pattisapu as a potential candidate for treating Childhood Hydrocephalus.
Dr. Jogi Pattisapu is a practicing pediatric neurosurgen and principal of Pediatric Neurosurgery and Childhood Hydrocephalus Center of Orlando, Florida. He is currently researching advanced treatments for Childhood Hydrocephalus in order to find alternatives to the shunt brain surgeries that are the currently accepted treatment for this ailment.
"The opportunity to participate in potentially ground breaking research into the treatment of an ailment that effects over 500,000 children will open up new possibilities for marketing the Company's innovative products into the medical biotech arena," said Steven M. Schorr, Chairman & CEO - Bioponic Phytoceuticals, Inc.
Bioponic Phytoceuticals is engaged in the formulation, production and distribution of Bioresonant Phytotherapeutic(TM) products for sale in the Complementary Alternative Medicine and natural products markets. The Company has developed a new patent pending healing modality "Bioresonant Phytotherapeutics" and has several branded product lines currently in national distribution (including the noted natural nasal spray: Flight Spray®). www.bioponic.com, and www.flightspray.com
Contact: Steven M. Schorr, CEO
Bioponic Phytoceuticals
info@bioponic.com
phone: 808-876-1711
Certain statements contained in this press release are forward-looking statements within the meaning of federal securities laws.
NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS RELEASE. THE PINK SHEETS LLC DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Press Release Source: Bioponic Phytoceuticals, Inc.
MAUI, Hawaii, June 27 /PRNewswire-FirstCall/ -- Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC: BPYT - News) today announced that all of its 11 product lines covering 83 products will be immediately available for sale on Amazon.com's online stores.
Bioponic Phytoceuticals is a provider of innovative natural products for sale in the Complementary Alternative Medicine and natural products markets. It has introduced and has received national exposure for its product "Flight Spray®" (as seen on Good Morning America and ABC News.com), and has positioned, Hawaiian Healing Mist®, O-Spray(TM), Throat Note(TM), Traveler's 1st Aid®, Curecumin(TM), Auntie Mahi Poe Poe's Tonics, Ginzeng!, Noni Care(TM), Liquid Essence and Liquid Sense(TM) products for national distribution.
Amazon.com, Inc. is a Fortune 500 company (www.amazon.com). They operate virtual stores on the World Wide Web and today offer the "Earth's Biggest Selection" of consumer products.
"Availability of the Company's 83 products on Amazon.com's online stores provides excellent market exposure for our 11 product lines to their (approximately) 60 million daily visitors. We anticipate that inclusion on their web site's online stores will help facilitate the Company's sales goals for 2006 and beyond," said Steven M. Schorr, Chairman & CEO, Bioponic Phytoceuticals, Inc.
About Bioponic:
Bioponic Phytoceuticals is engaged in the formulation, production and distribution of Bioresonant Phytotherapeutic(TM) products for sale in the Complementary Alternative Medicine and natural products markets. The Company has developed a new patent pending healing modality "Bioresonant Phytotherapeutics" and has several branded product lines currently in national distribution (including the noted natural nasal spray: Flight Spray®). Bioponic is presently focused on the production of natural products that are used by consumers to promote health and well being, and to help prevent disease. www.bioponic.com, and www.flightspray.com
Contact: Steven M. Schorr
Bioponic Phytoceuticals
info@bioponic.com
phone: 808-876-1711
Certain statements contained in this press release are forward-looking statements within the meaning of federal securities laws. Such statements are based largely on the Company's expectations and actual results may differ significantly from those presented herein. These forward-looking statements involve risks and uncertainties that include, among others, risks related to fluctuations in operating results.
NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS RELEASE. THE PINK SHEETS LLC DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
Source: Bioponic Phytoceuticals, Inc.
Press Release
Source: Bioponic Phytoceuticals, Inc.
Bioponic Phytoceuticals announces commencement of trading on the NASDAQ Pink Sheets
KULA, MAUI, HAWAII, Date June 5, 2006 /PRNewswire-FirstCall/ -Bioponic Phytoceuticals, Inc. ("Bioponic" or "the Company") (OTC PK: BPYT) today announced that Shares of Bioponic Phytoceuticals, Inc.’s common stock will be traded on the Nasdaq Pink Sheets Market under the trading symbol "BPYT".
Bioponic Phytoceuticals is a leading provider of innovative natural products for sale in the Complementary Alternative Medicine (“CAM”) and natural products markets. The Company’s primary products employ a new, patent pending healing modality “Bioresonant Phytotherapeutics™”, and it has introduced the national recognized product “Flight Spray” into national distribution (Magellan’s travel catalog, Drugstore.com, TravelSmith.com and others).
"I am delighted that the Company has taken this important step. We anticipate that the creation of a market for the Company’s stock will advance its strategy to aggressively pursue its sales goals for 2006," said Steven M. Schorr, Chairman & CEO - Bioponic Phytoceuticals, Inc.
This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful.
About Bioponic
Bioponic Phytoceuticals is engaged in the development, formulation, production and distribution of Bioresonant Phytotherapeutic™ products for sale in the Complementary Alternative Medicine (“CAM”) and natural products markets. The Company has developed a new healing modality “Bioresonant Phytotherapeutics™” and several branded product lines currently in distribution (including the nationally recognized natural nasal spray: Flight Spray™). Bioponic is presently focused on the production of natural products that are used by consumers to promote health and well-being, and to prevent disease. www.bioponic.com
Contact:
Steven M Schorr
Bioponic Phytoseuticals
808-876-1711
NO REGULATORY AUTHORITY HAS APPROVED OR DISAPPROVED THE CONTENT OF THIS RELEASE. THE NASDAQ PINK SHEET EXCHANGE DOES NOT ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
| 
